Pacira Biosciences, Inc. (PCRX)
24.96
+0.10
(+0.40%)
USD |
NASDAQ |
Aug 25, 11:29
Pacira Biosciences 1 Year Total Returns (Daily) : -3.79% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -3.79% |
| August 21, 2026 | -2.84% |
| August 20, 2026 | -4.64% |
| August 19, 2026 | -3.30% |
| August 18, 2026 | -3.58% |
| August 17, 2026 | -6.21% |
| August 14, 2026 | -7.96% |
| August 13, 2026 | -7.43% |
| August 12, 2026 | -4.47% |
| August 11, 2026 | -3.22% |
| August 10, 2026 | -2.98% |
| August 07, 2026 | 5.26% |
| August 06, 2026 | 14.20% |
| August 05, 2026 | 10.34% |
| August 04, 2026 | 20.40% |
| August 03, 2026 | 21.98% |
| July 31, 2026 | 25.23% |
| July 30, 2026 | 23.89% |
| July 29, 2026 | 22.17% |
| July 28, 2026 | 21.59% |
| July 27, 2026 | 17.38% |
| July 24, 2026 | 18.61% |
| July 23, 2026 | 16.54% |
| July 22, 2026 | 14.09% |
| July 21, 2026 | 16.28% |
| Date | Value |
|---|---|
| July 20, 2026 | 17.42% |
| July 17, 2026 | 14.89% |
| July 16, 2026 | 13.27% |
| July 15, 2026 | 11.44% |
| July 14, 2026 | 7.29% |
| July 13, 2026 | 11.53% |
| July 10, 2026 | 7.56% |
| July 09, 2026 | 10.06% |
| July 08, 2026 | 10.09% |
| July 07, 2026 | 11.20% |
| July 06, 2026 | 10.21% |
| July 02, 2026 | 9.39% |
| July 01, 2026 | 7.66% |
| June 30, 2026 | 6.15% |
| June 29, 2026 | 6.86% |
| June 26, 2026 | 6.45% |
| June 25, 2026 | 1.92% |
| June 24, 2026 | -2.68% |
| June 23, 2026 | -4.97% |
| June 22, 2026 | -6.27% |
| June 18, 2026 | -7.54% |
| June 17, 2026 | -7.18% |
| June 16, 2026 | -6.24% |
| June 15, 2026 | -6.19% |
| June 12, 2026 | -5.97% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Zimmer Biomet Holdings, Inc. | -5.27% |
| Liquidia Corp. | 161.8% |
| Johnson & Johnson | 56.09% |
| Merck & Co., Inc. | 78.24% |
| ANI Pharmaceuticals, Inc. | -18.50% |